Cargando…
Optimized Anti–Prostate‐Specific Membrane Antigen Single‐Chain Variable Fragment–Loaded Nanobubbles as a Novel Targeted Ultrasound Contrast Agent for the Diagnosis of Prostate Cancer
OBJECTIVES: To prepare optimized prostate‐specific membrane antigen (PSMA) single‐chain variable fragment (scFv)–loaded nanobubbles (NBs) as a novel targeted ultrasound (US) contrast agent for diagnosis and treatment of prostate cancer (PCa). METHODS: Prostate‐specific membrane antigen scFv‐loaded N...
Autores principales: | Ding, Yu, Cao, Qifeng, Qian, Subo, Chen, Xiaolong, Xu, Yuhong, Chen, Jian, Shen, Haibo |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
John Wiley & Sons, Inc.
2019
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7155035/ https://www.ncbi.nlm.nih.gov/pubmed/31702068 http://dx.doi.org/10.1002/jum.15155 |
Ejemplares similares
-
Molecular imaging of orthotopic prostate cancer with nanobubble ultrasound contrast agents targeted to PSMA
por: Wang, Yu, et al.
Publicado: (2021) -
The Optimized Fabrication of Nanobubbles as Ultrasound Contrast Agents for Tumor Imaging
por: Cai, Wen Bin, et al.
Publicado: (2015) -
Characterization of the interaction of nanobubble ultrasound contrast agents with human blood components
por: Cooley, Michaela B., et al.
Publicado: (2022) -
Ultrasound-mediated nanobubble destruction (UMND) facilitates the delivery of A10-3.2 aptamer targeted and siRNA-loaded cationic nanobubbles for therapy of prostate cancer
por: Wu, Meng, et al.
Publicado: (2018) -
Nanobubbles as ultrasound contrast agent for facilitating small cell lung cancer imaging
por: Wang, Jin-Ping, et al.
Publicado: (2017)